To analyze pediatric PCR-confirmed Mycoplasma pneumoniae detections during the 2023/24 resurgence and compare clinical and laboratory differences between children with MPP mono-detection and those with MPP plus rhinovirus/enterovirus co-detection.
Key Findings:
A resurgence of Mycoplasma pneumoniae infections was noted post-pandemic, particularly in 2023/24.
Detection rates of MPP declined significantly during the COVID-19 pandemic.
Children with MPP plus RV/EV co-detection exhibited different clinical and laboratory characteristics compared to those with MPP mono-detection.
Interpretation:
Limitations:
The study is retrospective and may have biases related to data collection.
Subgroup sizes were modest, limiting the generalizability of findings.
Missing values were excluded on a variable-by-variable basis, which may affect the results.
